FDA Approved: PITAVASTATIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for pitavastatin from Aurobindo Pharma Limited (ANDA206015).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

SUPPL AP for PITAVASTATIN (PITAVASTATIN)